Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by Pandoraon May 18, 2022 1:54pm
146 Views
Post# 34692967

RE:RE:RE:RE:Howie will not leave

RE:RE:RE:RE:Howie will not leave
PeterG wrote:
I personal view is, that this is not the intention from Howard to build a big global company. Again, he is already 60 years old and his intention is to sell the company to the right price. The question in mind is what the right price is if we see two major deals this year: one with Big Pharma and one for pet diabetes? We will see!!


Does that suggest if he was in his mid-70's there might be more of an urgency?
I am over 80 -- time is becoming of the essence for me, I know that. And I wish it was only SBM, not a handful of dead, or presumably dead, horses. And most management is much younger with little apparent concern for time.

That's why they tell me I am supposed to be in dead GIC's. :-)) All perspectives become in the same view! :-))
<< Previous
Bullboard Posts
Next >>